NYSEMKT: NSRX
Nasus Pharma Ltd Stock Ownership - Who owns Nasus Pharma?

Insider buying vs selling

Have Nasus Pharma Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dan Benjamin TelemanChief Executive Officer2026-06-176,550$3.10
$20.31kBuy
Dan Benjamin TelemanChief Executive Officer2026-04-222,900$3.76
$10.90kBuy
Dan Benjamin TelemanChief Executive Officer2026-03-3115,000$2.04
$30.60kBuy

1 of 1

NSRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NSRX insiders and whales buy or sell their stock.

NSRX Shareholders

What type of owners hold Nasus Pharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Udi Gilboa16.43%1,924,476$5.12MInsider
Dalia Megiddo16.17%1,894,068$5.04MInsider
Ronnie Hershman11.43%1,338,463$3.56MInsider
Dan Benjamin Teleman1.40%163,541$435.02kInsider
Balyasny Asset Management LP0.01%898$2.39kInstitution
Cable Car Capital LP0.01%616$1.64kInstitution
Hudson Bay Capital Management LP0.00%134$356.44Institution
Bleichroeder LP0.00%89$236.74Institution
Renaissance Technologies LLC0.00%14$37.24Institution
Pinnacle Financial Group Inc0.00%9$23.94Institution

1 of 2

NSRX vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NSRX0.02%45.43%Net Buying
MIRA0.01%18.36%
SCLX0.00%100.00%Net Selling
MDCX0.02%99.98%Net BuyingNet Buying
AMRN0.00%15.89%Net Selling

Nasus Pharma Stock Ownership FAQ

Who owns Nasus Pharma?

Nasus Pharma (NYSEMKT: NSRX) is owned by 0.02% institutional shareholders, 45.43% Nasus Pharma insiders, and 54.55% retail investors. Udi Gilboa is the largest individual Nasus Pharma shareholder, owning 1.92M shares representing 16.43% of the company. Udi Gilboa's Nasus Pharma shares are currently valued at $5.02M.

If you're new to stock investing, here's how to buy Nasus Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.